Moody's hits records at 31x earnings on a toll booth that still bends to the bond cycle

---

There is a particular kind of business that Wall Street loves with an intensity bordering on the religious: the toll booth. It does not manufacture anything. It does not carry inventory. It does not, in any meaningful sense, compete on price. It simply stands beside a road that everyone has to travel, collects a fee from each passing vehicle, and books an operating margin that would embarrass a luxury-goods house. Moody's Corporation is the platonic ideal of this business. When a company wants to sell a bond into the institutional market, the road runs through a Moody's rating — not as a courtesy, but as a regulatory and contractual near-necessity. The fee is small relative to the size of the deal and enormous relative to the cost of producing it. In the first quarter of 2026, that arrangement produced the best three months in the company's history.

On April 22, 2026, Moody's reported revenue of roughly $2.1 billion, up 8% year over year. Its ratings arm — Moody's Investors Service, or MIS — turned in record revenue of about $1.2 billion on more than $2 trillion of rated issuance, the first time quarterly rated volume has cleared that threshold. MIS posted a 67% adjusted operating margin. The Analytics arm, Moody's Analytics or MA, also grew 8%, with annual recurring revenue reaching $3.6 billion and an adjusted operating margin of 32.5%, up 250 basis points. Company-wide adjusted operating margin expanded to 53.2%. Adjusted diluted earnings per share came in at $4.33, up 13%. Management reaffirmed full-year adjusted EPS guidance of $16.40 to $17.00, lifted the buyback authorization to roughly $2.5 billion from $2.0 billion, and noted it had already returned $1.7 billion to shareholders in the quarter. It is, by any conventional reading, a triumphant report.

The market has paid accordingly. Moody's trades at roughly 31 times trailing earnings and about 25 times forward — a premium to the broad market and a multiple that, in the language of equity analysts, prices the company "for perfection." The thesis of this piece is not that Moody's is a bad business. It is, on the contrary, one of the finest businesses in the public market. The thesis is narrower and more uncomfortable: that a premium, secular multiple is being applied to a record that is, in critical part, the product of a cyclical wave — and that two of the structural pillars holding up that multiple, the inviolability of the analytics moat and the cleanliness of the reported earnings, are quietly less solid than the record quarter suggests.

The $2 trillion quarter is the tell, not the trend

Begin with the number management led with: more than $2 trillion of rated issuance in a single quarter, a first. It is a genuinely impressive figure, and it is exactly the figure a forensic reader should distrust most — not because it is wrong, but because it is the denominator of the whole bull case, and it is moving for reasons that have nothing to do with Moody's moat.

Bond issuance is not a stable subscription stream. It is a function of interest rates, credit spreads, corporate appetite for leverage, and the refinancing calendar — the wall of existing debt that comes due and must be rolled. When rates fall or stabilize after a tightening cycle, issuers rush to lock in financing; when refinancing maturities cluster, volume spikes regardless of the macro mood. The first quarter of 2026 caught both tailwinds: near-record investment-grade volumes, a refinancing wave, and — by management's own description — more than $100 billion of AI-related financing flowing through the rating machine in a single quarter. Private credit-related revenue inside MIS grew more than 80% year over year.

Each of those drivers is a reason to celebrate the quarter and a reason to question the multiple. AI-related financing of $100 billion-plus is the issuance equivalent of a sugar high: a wave of data-center and infrastructure debt being raised against a capital-spending boom that the bond market itself increasingly worries is overbuilt. Refinancing waves crest and recede. Investment-grade issuance that pulls forward to lock in rates pulls volume out of future quarters. None of this is a secret, and none of it is fraud. It is simply the unavoidable fact that MIS is a transaction business wearing a subscription business's valuation. The ratings cash cow does not generate a stable annuity; it generates a stream that swings with the debt-issuance cycle, and the cycle is currently at or near a high-water mark. A toll booth on a road with record traffic is a wonderful thing to own — right up until you remember that traffic is the variable, and you paid 31 times for the assumption that it only goes up.

Cyclical earnings, secular multiple

The cleanest way to see the mismatch is to hold the business model and the valuation in the same hand. Moody's MIS is, structurally, cyclical: its revenue is bond-volume-dependent, and bond volume is one of the more cyclical variables in all of finance. We have living memory of what the down-leg looks like. In the issuance droughts that follow rate shocks — the back half of 2022 is the textbook case — MIS revenue can fall double digits year over year, not because Moody's lost share or relevance, but because issuers simply stopped coming to market. The road emptied. The toll booth still stood there, immaculate and unchallenged, collecting almost nothing.

A 25-times-forward multiple is not a cyclical multiple. It is the multiple of a company whose earnings are assumed to compound smoothly and indefinitely. The bull resolves this tension by pointing at Moody's Analytics: the recurring-revenue, subscription-data business that now represents close to 45% of total revenue and grows in the high single digits with or without an issuance wave. The argument is that MA has "de-cyclicalized" the company, converting a transaction toll booth into a diversified data utility deserving of a utility-plus multiple.

It is a fair argument, and it is incomplete in a way that matters. MA grew 8% this quarter — solid, but not the 15-to-20% hypergrowth that would justify a standalone premium, and slower than the ratings arm in a good issuance year. More to the point, MA carries a 32.5% margin against MIS's 67%. The segment that is supposed to justify the secular multiple is the lower-margin, slower-compounding half of the company. The half doing the heavy lifting on both growth and profitability this quarter is precisely the cyclical, issuance-dependent half the multiple is supposed to be looking past. You are paying a secular price for a blended business whose profit engine is cyclical and whose stabilizer is the lower-margin growth-lite segment. That is not a moat problem. It is a mix-and-multiple problem, and it only reveals itself when the issuance wave recedes.

The build is bought, and bought growth flatters the organic line

Moody's Analytics is the keystone of the de-risking story, so it deserves a forensic look of its own. MA's $3.6 billion of annual recurring revenue is a genuinely valuable asset base — risk models, economic data, the BvD entity database covering hundreds of millions of companies, KYC and compliance tooling. But a meaningful share of that base did not grow there organically. It was acquired.

Moody's has spent the past decade assembling MA through acquisition: Bureau van Dijk for roughly $3.3 billion, RiskFirst, Reis, Regulatory DataCorp, Cortera, the long tail of bolt-ons in ESG, KYC, and supply-chain data. Each deal arrives bearing revenue, and each arrival flatters the consolidated growth line in the year it closes and the year after. The forensic discipline is to ask what MA grows at when you strip the acquisitions out — the true organic constant-currency rate. Moody's discloses organic ARR growth, and it is respectable, but the headline impression of a relentless compounding data machine is built partly on a cadence of purchases that consume cash, add goodwill and intangibles to the balance sheet, and require integration the segment margin has to absorb.

This is the bought-growth-masks-organic-stall frame, applied carefully. The claim is not that MA's growth is fake. It is that a portion of the "build" the bull case admires is a buy, that the buy has a price in cash and balance-sheet bloat, and that the durable organic rate underneath is slower and more ordinary than the acquisition-amplified headline. When you pay a premium for a "compounder," you are paying for organic compounding. To the extent the compounding is partly purchased, you are paying a compounder multiple for a serial acquirer — and serial acquirers, even excellent ones, deserve a discount for integration risk and capital-allocation dependency, not a premium.

$4.33 the company shows you, $3.73 the accountants made it report

Now the quality-of-earnings question, which is the most concrete of all. Moody's leads every release with adjusted diluted EPS. This quarter that figure was $4.33, up 13%. The GAAP diluted EPS — the number governed by accounting standards rather than management judgment — was $3.73. The adjusted number is roughly 16% higher than the number the accountants required the company to report.

A gap between adjusted and GAAP earnings is normal and not inherently sinister; the forensic discipline is to look at what lives in the gap and whether it recurs. For Moody's, the adjustments are dominated by amortization of acquired intangibles and by restructuring and acquisition-related charges. Here the bought-growth story and the quality-of-earnings story fuse into one. The very acquisition strategy that powers the MA narrative is what generates the intangible amortization that management asks investors to ignore each quarter. That amortization is a real economic cost — it is the using-up of assets Moody's paid billions of real dollars to acquire. Excluding it makes the margin look cleaner and the growth look richer, but the cash went out the door, and the asset is genuinely depreciating in value.

The point is not that $4.33 is a lie and $3.73 is the truth. It is that the headline the multiple is anchored to is the more flattering of the two figures, and the 16% wedge between them is not a one-time artifact — it is the structural and recurring consequence of a build-by-buying strategy. An investor paying 25 times forward earnings on the adjusted number is implicitly paying something closer to 29 times the GAAP number, on a business whose profit growth this quarter was led by its cyclical arm. The "perfection" priced in looks a little less perfect when you ask which earnings number you are actually buying.

The moat and the loophole: AI at the data utility's gate

The deepest pillar of the Moody's bull case is the moat, and the moat has two parts. The ratings half is protected by regulation and inertia: the NRSRO designations, the Basel and insurance frameworks that hard-code reliance on recognized agencies, and decades of issuer and investor habit. That moat is real and, for ratings, genuinely durable — no language model is going to acquire an NRSRO designation or rewrite Basel.

The analytics half is different, and this is where generative AI laps at the wall. MA sells what is, at bottom, data and analysis: credit risk scores, economic forecasts, entity data, research, compliance tooling. The premium it charges rests on the proposition that gathering, cleaning, modeling, and delivering this information is hard and that customers will pay handsomely for the incumbent's version rather than building their own. Large language models attack precisely that proposition. The fear, articulated across the sell side, is that LLMs could democratize financial analysis — letting a mid-tier asset manager or a corporate treasury generate credible credit assessments, entity research, and risk narratives in-house, at a fraction of the subscription cost, eroding the pricing power of the traditional data incumbents.

Moody's answer is that AI is its weapon, not its threat: it has begun embedding generative tools across MA, and it holds proprietary data on hundreds of millions of entities as the training substrate that outsiders cannot replicate. That is a serious rebuttal, and the proprietary-data argument is the strongest card in the deck. But it is a demonstration, not yet a deployment that has shown up as durable pricing power and accelerating organic growth. And it cuts both ways: if AI is powerful enough to be Moody's growth engine, it is powerful enough to be a competitor's cost-collapsing weapon against the very products MA sells. A moat that depends on the cost and difficulty of producing analysis is exposed when the cost of producing analysis falls toward zero. The ratings moat is a regulatory loophole no model can pick. The analytics moat is an economic one — and economic moats are exactly what cheap, capable AI erodes.

The denominator illusion in "record" everything

Management's release is a litany of records: record revenue, record MIS revenue, record issuance, record returns to shareholders. Records are emotionally persuasive and analytically thin. A business that grows even at a pedestrian rate sets a nominal revenue record nearly every year by sheer arithmetic — the bar is last year's number, and last year's number was a record too. The relevant question is never "is this a record" but "is this a record relative to the right denominator."

Apply that discipline to the $1.7 billion of capital returned and the buyback raised to $2.5 billion. Returning capital is shareholder-friendly, but a buyback funded at the top of an issuance cycle, at 31 times earnings, retires stock at a rich price. If the issuance wave recedes and earnings dip — as they did in the last droughts — the company will have spent peak-cycle cash buying peak-cycle-priced shares. That is not capital allocation genius; it is pro-cyclical buying dressed as confidence. The "record returns" headline measures dollars out the door, not value created per dollar. A company with $7.4 billion of debt and a net debt position levering an already-rich equity into buybacks at the cycle high is making a bet, not banking a certainty.

Demonstration versus deployment, and the guidance that didn't move

One quiet detail deserves emphasis: management reaffirmed full-year guidance rather than raising it on the back of a record quarter. After a first quarter that cleared $2 trillion in issuance for the first time ever and beat on EPS, the full-year adjusted EPS range stayed at $16.40 to $17.00. A management team that believed the strength was structural and repeatable would, all else equal, lean into it. Holding guidance flat after a blowout first quarter is the implicit admission that the quarter borrowed from the year — that the issuance surge is not assumed to recur at the same pace, and that the prudent base case still rests on a high-single-digit revenue trajectory rather than the low-double-digit pace Q1 alone implied. The market heard "record"; the guidance whispered "don't extrapolate." On a cyclical business priced for perfection, the second message is the one that matters.

What the bulls genuinely get right

It would be dishonest to leave the impression that Moody's is a house of cards. It is not. It is one of the great franchises in capitalism, and the bull case is strong on its own terms — strong enough that this has been a losing stock to short for most of its public life.

Start with the ratings moat, because it is the real thing. The NRSRO designation, the regulatory embedding, the issuer-pays model, and the simple fact that bond buyers and indentures demand a recognized rating make MIS close to un-disruptable at the franchise level. AI does not threaten a regulatory license. New entrants have tried for decades and gotten nowhere; the duopoly with S&P Global is among the most durable competitive structures in any industry. A 67% segment margin is not an accident or an aberration — it is the natural equilibrium of a business with near-zero marginal cost and legally reinforced demand. That is a moat worth paying up for, and the bulls are right to.

The diversification story is also genuinely working, even after the skeptical read above. MA's $3.6 billion ARR base is real recurring revenue with high retention, and its margin expanded 250 basis points this quarter — evidence of operating discipline, not just acquisition sugar. The company converts earnings to cash at an enviable rate: free cash flow of roughly $844 million in the quarter, up 26%, on operating cash flow up 24%. A business that throws off cash like that, buys back stock, raises its dividend, and grows the recurring base through cycles has earned a premium to the average company. And the AI-as-weapon thesis is not pure spin: Moody's proprietary entity data genuinely is a defensible training asset, and if any data incumbent turns generative AI from threat into moat-deepener, the one sitting on hundreds of millions of proprietary entity records is a credible candidate. The bull case is not wrong. It is priced. The disagreement is entirely about the price.

The kicker

Every forensic case on a great business comes down to the same question, and Moody's poses it more sharply than most: you are not being asked whether the company is excellent — it plainly is — but whether the price already assumes an excellence that the next down-leg of the debt cycle will interrupt. The records are real. The moat on ratings is real. The cash is real. What is not real is the implicit promise inside a 31-times multiple that the $2 trillion issuance quarter is a floor rather than a peak, that the analytics build will keep compounding faster than the AI that is learning to do its job, and that $4.33 is the honest number while $3.73 is a technicality. Strip those three assumptions and you do not get a short; you get a wonderful business at a price that requires the debt cycle to stay abolished and the language models to stay polite — two things the bond market has never once, in its entire history, agreed to do.

The toll booth is immaculate and the road is busy today, but you paid full price for the traffic, and traffic is the one thing on that road that has always, eventually, thinned.